Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05591404

Investigating the Effects of Social Stress on Brain Imaging

The purpose of this study is to examine whether experiencing a social stressor prior to the collection of neuroimaging measures is associated with differences in brain activation in healthy participants.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Age range

18 year–55 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Massachusetts Institute of Technology

Cambridge, Massachusetts, 02139, United States

Location status: Recruiting

Location contact

John Gabrieli, PhD

PRINCIPAL_INVESTIGATOR

Omar Rutledge, MS

CONTACT

[email protected]

617-324-2898

About this study

Using a randomized, parallel-group study design, this scientific investigation will examine the effect that experiencing the Trier Social Stress Test (TSST), the gold-standard for ethically inducing stress in a controlled laboratory setting, may have on neuroimaging measures of anxiety in healthy subjects. The study will enroll 50 healthy subjects who will be randomized to either experience the TSST or watch a nature film prior to undergoing task-based neuroimaging measures of emotional processing and self-referential processing using functional magnetic resonance imaging (fMRI).

This study will be conducted primarily at Massachusetts Institute of Technology with research and clinical support from Massachusetts General Hospital.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Ability and willingness to provide written informed consent.
  • Sufficiently fluent in English to participate in the trial.
  • Between 18-55 years of age (inclusive).
  • Right-hand dominant.
  • Current medications are stable for past 30 days (no changes to dose or frequency).
  • Negative result on pregnancy test (if female).
  • Negative result on urine drug screening.
  • Liebowitz Social Anxiety Scale (LSAS <30).

Exclusion criteria

  • History of bipolar disorder, schizophrenia, psychosis, delusional disorders.
  • History of eating disorder within past 6 months.
  • History of any traumatic brain injury.
  • Currently diagnosed with diabetes mellitus.
  • Presence of severe medical illness that would prevent completion of study procedures.
  • Presence of significant neurological illness or cognitive dysfunction (e.g.; seizures, dementia).
  • History of substance use disorder within past 6 months (other than nicotine and caffeine).
  • Use of any cannabis-containing products in past 30 days (CBD or THC).
  • Use of benzodiazepines in past 2 weeks.
  • Use of alpha- or beta-blockers in the past week.
  • History of claustrophobia.
  • Contraindications for MRI (e.g.; shrapnel).
  • Presence of any other medical condition that, in the investigator's opinion, may interfere with the study procedures.

Treatment and study plan

Trier Social Stress Test (TSST)

Behavioral

Participants randomized to the TSST arm will experience the Trier Social Stress Test.

Primary outcomes

  1. Differences in fMRI BOLD Response

    Time frame: 45 minutes after TSST

    Patterns of brain activation measured as blood-oxygenation-level dependent (BOLD) signals will be assessed using 3.0 Tesla (3T) functional magnetic resonance imaging (fMRI). Several exploratory imaging paradigms, including the emotional face-matching task (EFMT) and the self-referential comment task (SRCT), will be used to examine differences between participants who experience the TSST and those who do not.

Secondary outcomes

  1. Change in Acute Subjective Anxiety

    Time frame: -180 minutes, -15 minutes, -5 minutes, +10 minutes, +20 minutes, +30 minutes

    Subjective anxiety will be assessed with a modified Visual Analog Mood Scale (VAMS) which utilizes a vertical 100 millimeter (mm) bipolar visual scale between two opposing moods consisting of the following word pairs: calm-excited, relaxed-tense, and tranquil-troubled. Total subjective anxiety for each timepoint will be the average distance from the top for the three-question battery. VAMS will be assessed 180 minutes before start of TSST, 15 minutes before start of TSST, 5 minutes before start of TSST during the Anticipation phase, after the Stress Procedures (+10 minutes after start of TSST), after 5 minutes in the Recovery Phase (+20 minutes after start of TSST), and 15 minutes after start of the Recovery Phase (+30 minutes after start of TSST).

  2. Differences in Salivary Alpha Amylase

    Time frame: -180 minutes, -15 minutes, -5 minutes, +10 minutes, +20 minutes, +30 minutes

    Physiological stress will be assessed indirectly with salivary alpha amylase (sAA) activity which is regulated by the sympathetic branch of the autonomic nervous system. Samples will be collected using the SalivaBio Oral Swab (SOS) from Salimetrics. Participants will place the SOS in their mouth for 1-2 minutes at each timepoint to collect saliva. sAA will be assessed 180 minutes before start of TSST, 15 minutes before start of TSST, 5 minutes before start of TSST during the anticipation phase, after the Stress Procedures (+10 minutes after start of TSST), after 5 minutes in the Recovery Phase (+20 minutes after start of TSST), and 15 minutes after start of the Recovery Phase (+30 minutes after start of TSST).

Study contacts

Contact information is provided by the study sponsor or research team.

Omar Rutledge, MS

CONTACT

[email protected]

617-324-2898

Sponsors and collaborators

Lead sponsor

Massachusetts Institute of Technology

Other

Collaborators

  • Massachusetts General Hospital

Registry information

Acronym: SSBI

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Oct 24, 2022
Registry last updated
Dec 3, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.